Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin
Authors:
- 21 March 2007
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 28 (4) , 157-166
Abstract
It was reported that the expression of CYP3A1 increased in rats with acute renal failure induced by uranyl nitrate (rat model of U‐ARF) compared with controls. It was shown that telithromycin was mainly metabolized via CYP3A1/2 in rats in this study. Hence, the pharmacokinetic parameters of telithromycin were compared after both intravenous and oral administration at a dose of 50 mg/kg to control rats and a rat model of U‐ARF. After intravenous administration of telithromycin to rats with U‐ARF, the AUC and renal clearance (Clr) were significantly greater (35.0% increase) and slower (99.1% decrease), respectively, than the controls. Unexpectedly, the nonrenal clearance (Clnr) of telithromycin was comparable between the two groups of rats, suggesting that CYP3A isozyme responsible for the metabolism of telithromycin seemed not to be expressed considerably in the rat model of U‐ARF. After oral administration of telithromycin to rats with U‐ARF, the AUC was also significantly greater (127% increase) than the controls and the value, 127%, was considerably greater than 35.0% after intravenous administration of telithromycin. This may be due mainly to the decrease in the intestinal first‐pass effect of telithromycin compared with controls in addition to significantly slower Clr than controls. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 38 references indexed in Scilit:
- Pharmacokinetic Changes of Drugs in Rat Model of Acute Renal Failure Induced by Uranyl Nitrate: Correlation Between Drug Metabolism and Hepatic Microsomal Cytochrome P450 IsozymesCurrent Clinical Pharmacology, 2006
- Successful Telithromycin Therapy of Legionella PneumoniaKansenshogaku Zasshi, 2006
- Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniaeJournal of Infection, 2005
- Telithromycin: The first ketolide antimicrobialClinical Therapeutics, 2005
- Cuadro clínico y factores pronósticos de la neumonía adquirida en la comunidad grave en adultos hospitalizados en la unidad de cuidados intensivosArchivos de Bronconeumología, 2005
- EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATSDrug Metabolism and Disposition, 2003
- Increase in Urea in Conjunction with l-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal FailureDrug Metabolism and Disposition, 2002
- Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infectionsExpert Opinion on Investigational Drugs, 2001
- Pharmacokinetics of the New Ketolide Telithromycin (HMR 3647) Administered in Ascending Single and Multiple DosesAntimicrobial Agents and Chemotherapy, 2001
- Inhibition of Translation and 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells by 11 Different Ketolide AntibioticsCurrent Microbiology, 1998